Study Comparing Racivir and Lamivudine in Treatment-Experienced HIV Subjects
NCT00121979
·
clinicaltrials.gov ↗
PHASE2
Phase
COMPLETED
Status
60
Enrollment
INDUSTRY
Sponsor class
Conditions
HIV Infections
Interventions
DRUG:
Racivir, a non-nucleoside reverse transcriptase inhibitor
Sponsor
Pharmasset